Evidence map›Paper›PMID 37208376›Full record

ArticleNature reviews. Disease primers2023

Author Correction: Chikungunya fever.

Koen Bartholomeeusen, Matthieu Daniel, Desiree A LaBeaud, Philippe Gasque, Rosanna W Peeling, Kathryn E Stephenson, Lisa F P Ng, Kevin K Ariën

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Disease primers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Koen BartholomeeusenVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Matthieu DanielUnité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France.
Desiree A LaBeaudDepartment of Pediatrics, Division of Infectious Disease, Stanford University School of Medicine, Stanford, CA, USA.
Philippe GasqueUnité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France.
Rosanna W PeelingClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Kathryn E StephensonBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3440-4105
Lisa F P NgA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0003-4071-5222
Kevin K AriënVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. karien@itg.be.ORCID http://orcid.org/0000-0002-1340-4165

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37208376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.